Intrahepatic cholestasis of pregnancy
Clinical trials for Intrahepatic cholestasis of pregnancy explained in plain language.
Never miss a new study
Get alerted when new Intrahepatic cholestasis of pregnancy trials appear
Sign up with your email to follow new studies for Intrahepatic cholestasis of pregnancy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an experimental drug ease a pregnancy liver condition?
Symptom relief Not yet recruitingIntrahepatic cholestasis of pregnancy is a liver condition that causes severe itching and can pose risks to both mother and baby. Researchers are testing whether an oral drug called maralixibat is safe and well tolerated in pregnant women with this condition. All 15 participants …
Matched conditions: INTRAHEPATIC CHOLESTASIS OF PREGNANCY
Phase 2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
One shot during c-section may stop unbearable itching for moms with liver condition
Symptom relief Not yet recruitingThis study tests whether giving a single intravenous dose of esketamine during a C-section can reduce the intense itching that often follows surgery in women with intrahepatic cholestasis of pregnancy. 160 women will be randomly assigned to receive either esketamine or a placebo …
Matched conditions: INTRAHEPATIC CHOLESTASIS OF PREGNANCY
Sponsor: Tianjin Medical University General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New hope for Moms-to-Be: drug targets dangerous pregnancy itch
Symptom relief Not yet recruitingThis early-stage study tests a drug called maralixibat in 28 pregnant women with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching and high bile acids. The main goal is to see if the drug is safe and tolerable for both mother and baby. Rese…
Matched conditions: INTRAHEPATIC CHOLESTASIS OF PREGNANCY
Phase 2 • Sponsor: Imperial College London • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC